Cargando…
Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention
OBJECTIVE: Various nanoparticles have been designed and tested in order to select optimal carriers for the inhalation delivery of anticancer drugs to the lungs. METHODS: The following nanocarriers were studied: micelles, liposomes, mesoporous silica nanoparticles (MSNs), poly propyleneimine (PPI) de...
Autores principales: | Garbuzenko, Olga B., Mainelis, Gediminas, Taratula, Oleh, Minko, Tamara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969800/ https://www.ncbi.nlm.nih.gov/pubmed/24738038 http://dx.doi.org/10.7497/j.issn.2095-3941.2014.01.004 |
Ejemplares similares
-
Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy
por: Garbuzenko, Olga B., et al.
Publicado: (2019) -
Biodegradable Janus Nanoparticles for Local Pulmonary
Delivery of Hydrophilic and Hydrophobic Molecules to the Lungs
por: Garbuzenko, Olga B., et al.
Publicado: (2014) -
Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage
por: Betigeri, Seema, et al.
Publicado: (2010) -
Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
por: Majumder, Joydeb, et al.
Publicado: (2020) -
Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers
por: Garbuzenko, O.B., et al.
Publicado: (2019)